PHILADELPHIA – A new study of the most commonly prescribed post-kidney transplant drug suggests it may not be the most effective weapon to fend off organ rejection and may even damage some donor kidneys. The research, to be presented Nov. 2 at the American Society of Nephrology annual meeting, identified another drug that seems to work better, a finding that could help expand the pool of donor organs.
The above story is based on materials provided by Ohio University. Note: Materials may be edited for content and length.
Cite This Page:
Ohio University. "Studies Offer New Treatment Option To Prevent Kidney Rejection." ScienceDaily. ScienceDaily, 30 October 2002. <www.sciencedaily.com/releases/2002/10/021030074058.htm>.
Ohio University. (2002, October 30). Studies Offer New Treatment Option To Prevent Kidney Rejection. ScienceDaily. Retrieved March 7, 2014 from www.sciencedaily.com/releases/2002/10/021030074058.htm
Ohio University. "Studies Offer New Treatment Option To Prevent Kidney Rejection." ScienceDaily. www.sciencedaily.com/releases/2002/10/021030074058.htm (accessed March 7, 2014).